Piramal Enterprises Limited

Piramal Enterprises Limited manufactures and sells pharmaceutical, medicinal, and chemical and botanical products in India and internationally. It operates in Pharmaceuticals Manufacturing and Services, Financial Services, and Healthcare Insights & Analytics segments. The company offers contract development and manufacturing solutions across the drug life cycle, including drug discovery, development, and commercial manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms. It also provides inhalation anaesthetics comprising Sevoflurane, Isoflurane, and Halothane; injectable anaesthesia/pain management products that include Sublimaze, Sufenta, Rapifen, Dipidolor, and Hypnomidate; intrathecal severe spasticity/pain management products, which comprise Gablofen; and API generics, and vitamins and premixes. In addition, the company offers OTC products for skin care, pain management, oral care, respiratory, gastro-intestinal, lifestyle, and kids wellbeing under the Saridon, Lacto Calamine, I-Pill, Tetmosol, Polycrol, Naturolax, Caladryl, and Little's brands; and PhytoMedicines products to manage lifestyle ailments, such as diabetes, arthritis, obesity, constipation, liver damage, anxiety, sexual dysfunction, cough and cold, etc. Further, it provides real estate wholesale lending, corporate finance, corporate lending, alternative asset management, housing finance, investment, and stressed asset services. Additionally, the company offers custom data and analytics, consulting, managed, and learning services; and research and data products to pharma companies, payers, and providers. Piramal Enterprises Limited has strategic alliances with CPPIB Credit Investment Inc., APG Asset Management, Bain Capital Credit, and Ivanhoé Cambridge. The company was formerly known as Piramal Healthcare Limited and changed its name to Piramal Enterprises Limited in July 2012. Piramal Enterprises Limited was incorporated in 1947 and is headquartered in Mumbai, India.